PT  - JOURNAL ARTICLE
AU  - Han, Shuxin
AU  - Chiang, John Y. L.
TI  - Mechanism of Vitamin D Receptor Inhibition of Cholesterol 7α-Hydroxylase Gene Transcription in Human Hepatocytes
AID  - 10.1124/dmd.108.025155
DP  - 2009 Mar 01
TA  - Drug Metabolism and Disposition
PG  - 469--478
VI  - 37
IP  - 3
4099  - http://dmd.aspetjournals.org/content/37/3/469.short
4100  - http://dmd.aspetjournals.org/content/37/3/469.full
SO  - Drug Metab Dispos2009 Mar 01; 37
AB  - Lithocholic acid (LCA) is a potent endogenous vitamin D receptor (VDR) ligand. In cholestasis, LCA levels increase in the liver and intestine. The objective of this study is to test the hypothesis that VDR plays a role in inhibiting cholesterol 7α-hydroxylase (CYP7A1) gene expression and bile acid synthesis in human hepatocytes. Immunoblot analysis has detected VDR proteins in the nucleus of the human hepatoma cell line HepG2 and human primary hepatocytes. 1α, 25-Dihydroxy-vitamin D3 or LCA acetate-activated VDR inhibited CYP7A1 mRNA expression and bile acid synthesis, whereas small interfering RNA to VDR completely abrogated VDR inhibition of CYP7A1 mRNA expression in HepG2 cells. Electrophoretic mobility shift assay and mutagenesis analyses have identified the negative VDR response elements that bind VDR/retinoid X receptor α in the human CYP7A1 promoter. Mammalian two-hybrid, coimmunoprecipitation, glutathione S-transferase pull-down, and chromatin immunoprecipitation assays show that ligand-activated VDR specifically interacts with hepatocyte nuclear factor 4α (HNF4α) to block HNF4α interaction with coactivators or to compete with HNF4α for coactivators or to compete for binding to CYP7A1 chromatin, which results in the inhibition of CYP7A1 gene transcription. This study shows that VDR is expressed in human hepatocytes and may play a critical role in the inhibition of bile acid synthesis, thus protecting liver cells during cholestasis. The American Society for Pharmacology and Experimental Therapeutics